id | C00002708 |
---|---|
Name | Rottlerin |
CAS RN | 82-08-6 |
Standard InChI | InChI=1S/C30H28O8/c1-15-24(33)19(27(36)22(16(2)31)25(15)34)14-20-26(35)18-12-13-30(3,4)38-29(18)23(28(20)37)21(32)11-10-17-8-6-5-7-9-17/h5-13,33-37H,14H2,1-4H3/b11-10+ |
Standard InChI (Main Layer) | InChI=1S/C30H28O8/c1-15-24(33)19(27(36)22(16(2)31)25(15)34)14-20-26(35)18-12-13-30(3,4)38-29(18)23(28(20)37)21(32)11-10-17-8-6-5-7-9-17/h5-13,33-37H,14H2,1-4H3 |
Phytochemical cluster | No. 67 |
---|---|
KCF-S cluster | No. 3672 |
By standard InChI | CHEMBL34241 |
---|---|
By standard InChI Main Layer | CHEMBL34241 CHEMBL1330502 |
By LinkDB | C10721 |
---|
By CAS RN | C085746 |
---|
class name | count |
---|---|
rosids | 2 |
family name | count |
---|---|
Euphorbiaceae | 2 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Mallotus philippensis | 316645 | Euphorbiaceae | rosids | Viridiplantae |
Rottlera tinctoria | 3977 | Euphorbiaceae | rosids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1330502 |
CHEMBL1741321
(1)
|
1 / 0 |
Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | CHEMBL34241 |
CHEMBL1060147
(1)
|
1 / 1 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL1330502 |
CHEMBL1613992
(1)
|
7 / 44 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | CHEMBL34241 |
CHEMBL1061149
(1)
|
0 / 0 |
Q8TDX7 | Serine/threonine-protein kinase Nek7 | Nek | CHEMBL34241 |
CHEMBL1052109
(1)
|
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL34241 |
CHEMBL1613842
(3)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL34241 |
CHEMBL1794367
(1)
CHEMBL2114784
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL34241 |
CHEMBL1794499
(2)
|
2 / 0 |
Q15759 | Mitogen-activated protein kinase 11 | p38 | CHEMBL34241 |
CHEMBL1062016
(1)
CHEMBL1247634
(1)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL34241 |
CHEMBL1062824
(1)
CHEMBL1247633
(1)
|
0 / 0 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL34241 |
CHEMBL1614079
(1)
|
0 / 0 |
O15530 | 3-phosphoinositide-dependent protein kinase 1 | Pdk1 | CHEMBL34241 |
CHEMBL1061083
(1)
|
0 / 0 |
P41240 | Tyrosine-protein kinase CSK | Csk | CHEMBL34241 |
CHEMBL1062002
(1)
|
0 / 0 |
P45984 | Mitogen-activated protein kinase 9 | Jnk | CHEMBL34241 |
CHEMBL1060121
(1)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL34241 |
CHEMBL1063727
(1)
CHEMBL1249530
(1)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL34241 |
CHEMBL1062009
(1)
|
0 / 0 |
Q05655 | Protein kinase C delta type | Delta | CHEMBL34241 |
CHEMBL766321
(1)
CHEMBL1249788
(1)
CHEMBL1931128 (1) |
0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL34241 |
CHEMBL1738600
(1)
|
0 / 0 |
O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | CHEMBL34241 |
CHEMBL1063732
(1)
CHEMBL1249541
(1)
|
0 / 0 |
Q8IWQ3 | Serine/threonine-protein kinase BRSK2 | CAMK serine/threonine protein kinase BRSK subfamily | CHEMBL34241 |
CHEMBL1051366
(1)
|
0 / 0 |
P27448 | MAP/microtubule affinity-regulating kinase 3 | CAMK serine/threonine protein kinase MARK subfamily | CHEMBL34241 |
CHEMBL1060203
(1)
|
0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL1330502 |
CHEMBL1614331
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL34241 |
CHEMBL1614310
(1)
CHEMBL1614544
(1)
|
11 / 10 |
Q05513 | Protein kinase C zeta type | Iota | CHEMBL34241 |
CHEMBL1061095
(1)
|
0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL34241 |
CHEMBL1061910
(1)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1330502 |
CHEMBL1614027
(1)
CHEMBL1741325
(1)
|
0 / 1 |
P23443 | Ribosomal protein S6 kinase beta-1 | p70 | CHEMBL34241 |
CHEMBL1061107
(1)
CHEMBL1249534
(1)
|
0 / 0 |
Q9UQB9 | Aurora kinase C | Aur | CHEMBL34241 |
CHEMBL1061993
(1)
|
1 / 1 |
Q9HBH9 | MAP kinase-interacting serine/threonine-protein kinase 2 | CAMK serine/threonine protein kinase MNK subfamily | CHEMBL34241 |
CHEMBL1060207
(1)
|
0 / 0 |
Q9NQU5 | Serine/threonine-protein kinase PAK 6 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL34241 |
CHEMBL1061082
(1)
|
0 / 0 |
Q16644 | MAP kinase-activated protein kinase 3 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL34241 |
CHEMBL1060201
(1)
|
0 / 0 |
Q9H422 | Homeodomain-interacting protein kinase 3 | CMGC dual-specificity kinase HIPK | CHEMBL34241 |
CHEMBL1063749
(1)
|
0 / 0 |
Q14680 | Maternal embryonic leucine zipper kinase | Melk | CHEMBL34241 |
CHEMBL1063735
(1)
|
0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL34241 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL34241 CHEMBL1330502 |
CHEMBL1794311
(5)
|
2 / 3 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | CHEMBL34241 |
CHEMBL1063674
(1)
|
1 / 1 |
Q13188 | Serine/threonine-protein kinase 3 | STE serine/threonine protein kinase MST subfamily | CHEMBL34241 |
CHEMBL1060149
(1)
|
0 / 0 |
P31751 | RAC-beta serine/threonine-protein kinase | Akt | CHEMBL34241 |
CHEMBL1062855
(1)
|
2 / 2 |
O75582 | Ribosomal protein S6 kinase alpha-5 | CAMK serine/threonine protein kinase MSKB subfamily | CHEMBL34241 |
CHEMBL1061974
(1)
CHEMBL1247639
(1)
|
0 / 0 |
O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | CHEMBL34241 |
CHEMBL1052097
(1)
|
0 / 0 |
Q16513 | Serine/threonine-protein kinase N2 | Pkn | CHEMBL34241 |
CHEMBL1062022
(1)
|
0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | CHEMBL34241 |
CHEMBL1060157
(1)
|
0 / 0 |
P17538 | Chymotrypsinogen B | S1A | CHEMBL34241 |
CHEMBL661258
(1)
|
0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL1330502 |
CHEMBL1613800
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL34241 CHEMBL1330502 |
CHEMBL1614458
(5)
|
0 / 0 |
Q8N5S9 | Calcium/calmodulin-dependent protein kinase kinase 1 | META serine/threonine protein kinase subfamily | CHEMBL34241 |
CHEMBL1061949
(1)
|
0 / 0 |
Q9P286 | Serine/threonine-protein kinase PAK 7 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL34241 |
CHEMBL1063810
(1)
|
0 / 0 |
Q8IXJ6 | NAD-dependent protein deacetylase sirtuin-2 | Enzyme | CHEMBL34241 |
CHEMBL913334
(1)
|
0 / 0 |
Q96SB4 | SRSF protein kinase 1 | Srpk | CHEMBL34241 |
CHEMBL1060224
(1)
|
0 / 0 |
Q92630 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | CMGC dual-specificity kinase DYRK2 | CHEMBL34241 |
CHEMBL1062007
(1)
|
0 / 0 |
O43781 | Dual specificity tyrosine-phosphorylation-regulated kinase 3 | CMGC dual-specificity kinase DYRK2 | CHEMBL34241 |
CHEMBL1062805
(1)
|
0 / 0 |
O96013 | Serine/threonine-protein kinase PAK 4 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL34241 |
CHEMBL1061161
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL34241 |
CHEMBL1794486
(2)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL34241 CHEMBL1330502 |
CHEMBL1738606
(4)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL34241 |
CHEMBL1613941
(1)
CHEMBL1738636
(1)
|
0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | CHEMBL34241 |
CHEMBL1052077
(1)
CHEMBL1249535
(1)
|
0 / 0 |
Q15418 | Ribosomal protein S6 kinase alpha-1 | Rskb | CHEMBL34241 |
CHEMBL1063777
(1)
|
0 / 0 |
O15264 | Mitogen-activated protein kinase 13 | p38 | CHEMBL34241 |
CHEMBL1063768
(1)
CHEMBL1247636
(1)
|
0 / 0 |
P53779 | Mitogen-activated protein kinase 10 | Jnk | CHEMBL34241 |
CHEMBL1062757
(1)
|
0 / 1 |
P51955 | Serine/threonine-protein kinase Nek2 | Nek | CHEMBL34241 |
CHEMBL1061977
(1)
|
0 / 0 |
Q96RR4 | Calcium/calmodulin-dependent protein kinase kinase 2 | META serine/threonine protein kinase subfamily | CHEMBL34241 |
CHEMBL1061996
(1)
|
0 / 0 |
Q9BUB5 | MAP kinase-interacting serine/threonine-protein kinase 1 | CAMK serine/threonine protein kinase MNK subfamily | CHEMBL34241 |
CHEMBL1061970
(1)
|
0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL34241 |
CHEMBL1794569
(1)
|
1 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL34241 |
CHEMBL1738610
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL34241 CHEMBL1330502 |
CHEMBL1794467
(3)
CHEMBL1794492
(1)
|
0 / 0 |
P61586 | Transforming protein RhoA | Unclassified protein | CHEMBL34241 |
CHEMBL1931129
(1)
|
0 / 0 |
P48730 | Casein kinase I isoform delta | Ck1 | CHEMBL34241 |
CHEMBL1061203
(1)
|
1 / 0 |
Q96GD4 | Aurora kinase B | Aur | CHEMBL34241 |
CHEMBL1062890
(1)
|
0 / 0 |
P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL34241 |
CHEMBL1060141
(1)
CHEMBL1247638
(1)
CHEMBL1249806 (1) |
0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | CHEMBL1330502 |
CHEMBL1614252
(1)
|
2 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL34241 |
CHEMBL1060115
(1)
CHEMBL1247631
(1)
|
0 / 0 |
P45983 | Mitogen-activated protein kinase 8 | Jnk | CHEMBL34241 |
CHEMBL1062814
(1)
CHEMBL1247632
(1)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1330502 |
CHEMBL1741322
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1330502 |
CHEMBL1613910
(1)
CHEMBL1614227
(2)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL1330502 |
CHEMBL1614038
(1)
|
2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL34241 |
CHEMBL1614171
(1)
|
5 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL34241 |
CHEMBL1738675
(1)
|
0 / 0 |
P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | CHEMBL34241 |
CHEMBL1061099
(1)
|
0 / 0 |
Q8IW41 | MAP kinase-activated protein kinase 5 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL34241 |
CHEMBL732638
(1)
CHEMBL1063666
(1)
CHEMBL1247640 (1) CHEMBL1249805 (1) |
0 / 0 |
O75116 | Rho-associated protein kinase 2 | Rock | CHEMBL34241 |
CHEMBL1063774
(1)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL1330502 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL1330502 |
CHEMBL1614240
(1)
|
0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL34241 |
CHEMBL1061171
(1)
CHEMBL1249532
(1)
|
4 / 1 |
Q15118 | [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial | Pdhk | CHEMBL34241 |
CHEMBL1249531
(1)
|
0 / 0 |
O00141 | Serine/threonine-protein kinase Sgk1 | AGC serine/threonine protein kinase SGK subfamily | CHEMBL34241 |
CHEMBL1060221
(1)
CHEMBL1249533
(1)
|
0 / 0 |
P51812 | Ribosomal protein S6 kinase alpha-3 | Rskb | CHEMBL34241 |
CHEMBL1052117
(1)
|
2 / 2 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1330502 |
CHEMBL1613777
(1)
CHEMBL1741323
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1330502 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
CHEMBL1741324 (1) |
0 / 1 |
Q9HC98 | Serine/threonine-protein kinase Nek6 | Nek | CHEMBL34241 |
CHEMBL1052108
(1)
|
0 / 0 |
Q9H2X6 | Homeodomain-interacting protein kinase 2 | CMGC dual-specificity kinase HIPK | CHEMBL34241 |
CHEMBL1062014
(1)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL34241 |
CHEMBL1794483
(2)
|
0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | CHEMBL34241 |
CHEMBL1614052
(1)
|
1 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL34241 |
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL34241 CHEMBL1330502 |
CHEMBL1614250
(3)
CHEMBL1614421
(5)
CHEMBL1614502 (5) |
4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | CHEMBL34241 |
CHEMBL1738402
(2)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL34241 |
CHEMBL1737980
(1)
|
0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL34241 |
CHEMBL1249540
(1)
|
0 / 1 |
O96017 | Serine/threonine-protein kinase Chk2 | Rad53 | CHEMBL34241 |
CHEMBL1052082
(1)
|
4 / 1 |
Q14012 | Calcium/calmodulin-dependent protein kinase type 1 | Camk1 | CHEMBL34241 |
CHEMBL1062799
(1)
|
0 / 0 |
P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | CHEMBL34241 |
CHEMBL1062780
(1)
|
0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | CHEMBL34241 |
CHEMBL1063743
(1)
|
1 / 0 |
P53778 | Mitogen-activated protein kinase 12 | p38 | CHEMBL34241 |
CHEMBL1060154
(1)
CHEMBL1247635
(1)
|
0 / 0 |
O00418 | Eukaryotic elongation factor 2 kinase | Atypical serine/threonine protein kinase alpha subfamily | CHEMBL34241 |
CHEMBL1052075
(1)
|
0 / 0 |
Q8TD08 | Mitogen-activated protein kinase 15 | Mapk | CHEMBL34241 |
CHEMBL1052076
(1)
|
0 / 0 |
Q86V86 | Serine/threonine-protein kinase pim-3 | Pim | CHEMBL34241 |
CHEMBL1051343
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL34241 CHEMBL1330502 |
CHEMBL1794536
(3)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL34241 CHEMBL1330502 |
CHEMBL1613914
(3)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL34241 |
CHEMBL1614330
(1)
CHEMBL1613829
(4)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL1330502 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL34241 |
CHEMBL1738442
(4)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL34241 CHEMBL1330502 |
CHEMBL1614364
(4)
|
1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL34241 |
CHEMBL2354311
(1)
|
1 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL34241 CHEMBL1330502 |
CHEMBL1614257
(3)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL34241 CHEMBL1330502 |
CHEMBL1614257
(3)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL34241 CHEMBL1330502 |
CHEMBL1613933
(3)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL34241 CHEMBL1330502 |
CHEMBL1613933
(3)
|
1 / 6 |
P20248 | Cyclin-A2 | Other cytosolic protein | CHEMBL34241 |
CHEMBL1061199
(1)
|
0 / 0 |
P78396 | Cyclin-A1 | Other cytosolic protein | CHEMBL34241 |
CHEMBL1061199
(1)
|
0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL34241 |
CHEMBL1061199
(1)
|
0 / 0 |
P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL34241 |
CHEMBL1052072
(1)
|
0 / 0 |
P19784 | Casein kinase II subunit alpha' | Ck2 | CHEMBL34241 |
CHEMBL1052072
(1)
|
0 / 0 |
P67870 | Casein kinase II subunit beta | REG serine/threonine protein kinase family | CHEMBL34241 |
CHEMBL1052072
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C085746 | 25 |
ABL1
ABL JTK7 bcr/abl c-ABL p150 v-abl |
c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) | rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] |
decreases activity
/ decreases reaction / increases expression / increases phosphorylation |
protein |
17030193
|
C085746 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C085746 | 578 |
BAK1
BAK BAK-LIKE BCL2L7 CDN1 |
BCL2-antagonist/killer 1 | rottlerin inhibits the reaction [Doxorubicin results in increased activity of BAK1 protein] |
decreases reaction
/ increases activity |
protein |
15917298
|
C085746 | 330 |
BIRC3
AIP1 API2 CIAP2 HAIP1 HIAP1 MALT2 MIHC RNF49 c-IAP2 |
baculoviral IAP repeat containing 3 | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] |
decreases reaction
/ increases expression |
mRNA |
14527959
|
C085746 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | rottlerin inhibits the reaction [NSC606985 results in increased activity of CASP3 protein] |
decreases reaction
/ increases activity |
protein |
19662097
|
C085746 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | rottlerin inhibits the reaction [Ursodeoxycholic Acid results in increased cleavage of CASP3 protein] |
decreases reaction
/ increases cleavage |
protein |
21362627
|
C085746 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | rottlerin results in increased activity of CASP3 protein |
increases activity
|
protein |
22410117
|
C085746 | 839 |
CASP6
MCH2 |
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) | rottlerin inhibits the reaction [Ursodeoxycholic Acid results in increased cleavage of CASP6 protein] |
decreases reaction
/ increases cleavage |
protein |
21362627
|
C085746 | 595 |
CCND1
BCL1 D11S287E PRAD1 U21B31 |
cyclin D1 | [sorafenib co-treated with rottlerin] results in decreased expression of CCND1 protein |
affects cotreatment
/ decreases expression |
protein |
16959960
|
C085746 | 896 |
CCND3
|
cyclin D3 | [sorafenib co-treated with rottlerin] results in decreased expression of CCND3 protein |
affects cotreatment
/ decreases expression |
protein |
16959960
|
C085746 | 952 |
CD38
T10 |
CD38 molecule (EC:3.2.2.5) | rottlerin inhibits the reaction [Tretinoin results in increased expression of CD38 mRNA] |
decreases reaction
/ increases expression |
mRNA |
21393419
|
C085746 | 952 |
CD38
T10 |
CD38 molecule (EC:3.2.2.5) | rottlerin inhibits the reaction [Tretinoin results in increased expression of CD38 protein] |
decreases reaction
/ increases expression |
protein |
21393419
|
C085746 | 1019 |
CDK4
CMM3 PSK-J3 |
cyclin-dependent kinase 4 (EC:2.7.11.22) | [sorafenib co-treated with rottlerin] results in decreased expression of CDK4 protein |
affects cotreatment
/ decreases expression |
protein |
16959960
|
C085746 | 1021 |
CDK6
PLSTIRE |
cyclin-dependent kinase 6 (EC:2.7.11.22) | [sorafenib co-treated with rottlerin] results in decreased expression of CDK6 protein |
affects cotreatment
/ decreases expression |
protein |
16959960
|
C085746 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] |
decreases reaction
/ increases expression |
protein |
15976015
|
C085746 | 1050 |
CEBPA
C/EBP-alpha CEBP |
CCAAT/enhancer binding protein (C/EBP), alpha | rottlerin inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] |
decreases expression
/ decreases reaction |
protein |
19662097
|
C085746 | 1050 |
CEBPA
C/EBP-alpha CEBP |
CCAAT/enhancer binding protein (C/EBP), alpha | rottlerin inhibits the reaction [NSC606985 results in increased ubiquitination of CEBPA protein] |
decreases reaction
/ increases ubiquitination |
protein |
19662097
|
C085746 | 1277 |
COL1A1
OI4 |
collagen, type I, alpha 1 | rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] |
decreases activity
/ decreases reaction / increases expression / increases phosphorylation |
protein |
17030193
|
C085746 | 1277 |
COL1A1
OI4 |
collagen, type I, alpha 1 | rottlerin inhibits the reaction [Acetaldehyde results in increased expression of COL1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17030193
|
C085746 | 1277 |
COL1A1
OI4 |
collagen, type I, alpha 1 | rottlerin inhibits the reaction [Acetaldehyde results in increased expression of COL1A1 protein] |
decreases reaction
/ increases expression |
protein |
17030193
|
C085746 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | rottlerin results in decreased activity of CYP19A1 protein |
decreases activity
|
protein |
15955695
|
C085746 | 1649 |
DDIT3
CEBPZ CHOP CHOP-10 CHOP10 GADD153 |
DNA-damage-inducible transcript 3 | rottlerin inhibits the reaction [Curcumin results in increased expression of DDIT3 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17171638
|
C085746 | 1649 |
DDIT3
CEBPZ CHOP CHOP-10 CHOP10 GADD153 |
DNA-damage-inducible transcript 3 | rottlerin results in increased expression of DDIT3 protein |
increases expression
|
protein |
22410117
|
C085746 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | rottlerin inhibits the reaction [irinotecan metabolite results in increased phosphorylation of EGFR protein] |
decreases reaction
/ increases phosphorylation |
protein |
15723263
|
C085746 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | rottlerin inhibits the reaction [irinotecan results in increased phosphorylation of EGFR protein] |
decreases reaction
/ increases phosphorylation |
protein |
15723263
|
C085746 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C085746 | 1977 |
EIF4E
AUTS19 CBP EIF4E1 EIF4EL1 EIF4F |
eukaryotic translation initiation factor 4E | rottlerin promotes the reaction [EIF4E protein binds to EIF4EBP1 protein] |
affects binding
/ increases reaction |
protein |
19771169
|
C085746 | 1978 |
EIF4EBP1
4E-BP1 4EBP1 BP-1 PHAS-I |
eukaryotic translation initiation factor 4E binding protein 1 | rottlerin inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19771169
|
C085746 | 1978 |
EIF4EBP1
4E-BP1 4EBP1 BP-1 PHAS-I |
eukaryotic translation initiation factor 4E binding protein 1 | rottlerin promotes the reaction [EIF4E protein binds to EIF4EBP1 protein] |
affects binding
/ increases reaction |
protein |
19771169
|
C085746 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of FOS protein] |
affects localization
/ decreases reaction |
protein |
20599481
|
C085746 | 9518 |
GDF15
GDF-15 MIC-1 MIC1 NAG-1 PLAB PTGFB |
growth differentiation factor 15 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [rottlerin results in increased expression of GDF15 protein] |
decreases reaction
/ increases expression |
protein |
22410117
|
C085746 | 9518 |
GDF15
GDF-15 MIC-1 MIC1 NAG-1 PLAB PTGFB |
growth differentiation factor 15 | GDF15 affects the susceptibility to rottlerin |
affects response to substance
|
22410117
|
|
C085746 | 9518 |
GDF15
GDF-15 MIC-1 MIC1 NAG-1 PLAB PTGFB |
growth differentiation factor 15 | rottlerin results in increased expression of GDF15 mRNA |
increases expression
|
mRNA |
22410117
|
C085746 | 9518 |
GDF15
GDF-15 MIC-1 MIC1 NAG-1 PLAB PTGFB |
growth differentiation factor 15 | rottlerin results in increased expression of GDF15 protein |
increases expression
|
protein |
22410117
|
C085746 | 9518 |
GDF15
GDF-15 MIC-1 MIC1 NAG-1 PLAB PTGFB |
growth differentiation factor 15 | SB 203580 inhibits the reaction [rottlerin results in increased expression of GDF15 protein] |
decreases reaction
/ increases expression |
protein |
22410117
|
C085746 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | rottlerin inhibits the reaction [2-butenal results in increased expression of HMOX1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
21238556
|
C085746 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | rottlerin inhibits the reaction [2-butenal results in increased expression of HMOX1 protein] |
decreases reaction
/ increases expression |
protein |
21238556
|
C085746 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | rottlerin inhibits the reaction [Acrolein results in increased expression of HMOX1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
18048804
|
C085746 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | rottlerin inhibits the reaction [Curcumin results in increased expression of HMOX1 protein] |
decreases reaction
/ increases expression |
protein |
18357586
|
C085746 | 3190 |
HNRNPK
CSBP HNRPK TUNP |
heterogeneous nuclear ribonucleoprotein K | rottlerin inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein] |
decreases expression
/ decreases reaction |
protein |
19747914
|
C085746 | 3309 |
HSPA5
BIP GRP78 MIF2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | rottlerin results in increased expression of HSPA5 protein |
increases expression
|
protein |
22410117
|
C085746 | 3440 |
IFNA2
IFN-alphaA IFNA IFNA2B INFA2 |
interferon, alpha 2 | rottlerin inhibits the reaction [IFNA2 protein results in increased expression of PLSCR1 mRNA] |
decreases reaction
/ increases expression |
protein |
16260419
|
C085746 | 3440 |
IFNA2
IFN-alphaA IFNA IFNA2B INFA2 |
interferon, alpha 2 | rottlerin inhibits the reaction [IFNA2 protein results in increased expression of PLSCR1 protein] |
decreases reaction
/ increases expression |
protein |
16260419
|
C085746 | 3440 |
IFNA2
IFN-alphaA IFNA IFNA2B INFA2 |
interferon, alpha 2 | rottlerin inhibits the reaction [IFNA2 protein results in increased phosphorylation of and results in increased activity of PRKCD protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
16260419
|
C085746 | 3558 |
IL2
IL-2 TCGF lymphokine |
interleukin 2 | rottlerin inhibits the reaction [pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]] |
affects cotreatment
/ decreases reaction / increases expression / increases reaction |
protein |
16241859
|
C085746 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | rottlerin inhibits the reaction [Deferoxamine results in increased expression of IL8 protein] |
decreases reaction
/ increases expression |
protein |
17097691
|
C085746 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of JUN protein] |
affects localization
/ decreases reaction |
protein |
20599481
|
C085746 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of JUN protein] |
decreases reaction
/ increases activity / increases expression |
protein |
18628248
|
C085746 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased phosphorylation of JUN protein] |
decreases reaction
/ increases expression / increases phosphorylation |
protein |
18628248
|
C085746 | 5604 |
MAP2K1
CFC3 MAPKK1 MEK1 MKK1 PRKMK1 |
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) | rottlerin results in decreased phosphorylation of MAP2K1 protein |
decreases phosphorylation
|
protein |
15949478
|
C085746 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | rottlerin inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
17030193
|
C085746 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C085746 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
18628248
20599481 |
C085746 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | [sorafenib co-treated with rottlerin] results in decreased phosphorylation of MAPK1 protein |
affects cotreatment
/ decreases phosphorylation |
protein |
16959960
|
C085746 | 1432 |
MAPK14
CSBP CSBP1 CSBP2 CSPB1 EXIP Mxi2 PRKM14 PRKM15 RK SAPK2A p38 p38ALPHA |
mitogen-activated protein kinase 14 (EC:2.7.11.24) | rottlerin results in decreased phosphorylation of MAPK14 protein |
decreases phosphorylation
|
protein |
15949478
|
C085746 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | rottlerin inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
17030193
|
C085746 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C085746 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
18628248
20599481 |
C085746 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | [sorafenib co-treated with rottlerin] results in decreased phosphorylation of MAPK3 protein |
affects cotreatment
/ decreases phosphorylation |
protein |
16959960
|
C085746 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | rottlerin inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK8 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15917298
|
C085746 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK8 protein] |
decreases reaction
/ increases phosphorylation |
protein |
20599481
|
C085746 | 5601 |
MAPK9
JNK-55 JNK2 JNK2A JNK2ALPHA JNK2B JNK2BETA PRKM9 SAPK SAPK1a p54a p54aSAPK |
mitogen-activated protein kinase 9 (EC:2.7.11.24) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] |
decreases reaction
/ increases phosphorylation |
protein |
20599481
|
C085746 | 4282 |
MIF
GIF GLIF MMIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1) | rottlerin inhibits the reaction [MIF protein results in increased expression of MMP2 protein] |
decreases reaction
/ increases expression |
protein |
16872482
|
C085746 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | rottlerin inhibits the reaction [MIF protein results in increased expression of MMP2 protein] |
decreases reaction
/ increases expression |
protein |
16872482
|
C085746 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] |
decreases reaction
/ increases activity |
protein |
20599481
|
C085746 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
20599481
|
C085746 | 2475 |
MTOR
FRAP FRAP1 FRAP2 RAFT1 RAPT1 |
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) | rottlerin inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19771169
|
C085746 | 4780 |
NFE2L2
NRF2 |
nuclear factor, erythroid 2-like 2 | rottlerin inhibits the reaction [Acrolein affects the localization of NFE2L2 protein] |
affects localization
/ decreases reaction |
protein |
18048804
|
C085746 | 4922 |
NTS
NMN-125 NN NT NT/N NTS1 |
neurotensin | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C085746 | 4922 |
NTS
NMN-125 NN NT NT/N NTS1 |
neurotensin | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C085746 | 4922 |
NTS
NMN-125 NN NT NT/N NTS1 |
neurotensin | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C085746 | 4922 |
NTS
NMN-125 NN NT NT/N NTS1 |
neurotensin | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C085746 | 5337 |
PLD1
|
phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4) | rottlerin inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] |
decreases reaction
/ increases expression / increases reaction |
protein |
17640750
|
C085746 | 5359 |
PLSCR1
MMTRA1B |
phospholipid scramblase 1 | rottlerin inhibits the reaction [IFNA2 protein results in increased expression of PLSCR1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
16260419
|
C085746 | 5359 |
PLSCR1
MMTRA1B |
phospholipid scramblase 1 | rottlerin inhibits the reaction [IFNA2 protein results in increased expression of PLSCR1 protein] |
decreases reaction
/ increases expression |
protein |
16260419
|
C085746 | 5468 |
PPARG
CIMT1 GLM1 NR1C3 PPARG1 PPARG2 PPARgamma |
peroxisome proliferator-activated receptor gamma | rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] |
decreases activity
/ decreases reaction / increases expression / increases phosphorylation |
protein |
17030193
|
C085746 | 5580 |
PRKCD
MAY1 PKCD nPKC-delta |
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | rottlerin inhibits the reaction [Curcumin results in increased phosphorylation of PRKCD protein] |
decreases reaction
/ increases phosphorylation |
protein |
17171638
|
C085746 | 5580 |
PRKCD
MAY1 PKCD nPKC-delta |
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | rottlerin inhibits the reaction [IFNA2 protein results in increased phosphorylation of and results in increased activity of PRKCD protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
16260419
|
C085746 | 5580 |
PRKCD
MAY1 PKCD nPKC-delta |
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | rottlerin inhibits the reaction [NSC606985 results in increased activity of and results in increased cleavage of PRKCD protein] |
decreases reaction
/ increases activity / increases cleavage |
protein |
19662097
|
C085746 | 5580 |
PRKCD
MAY1 PKCD nPKC-delta |
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | rottlerin results in decreased activity of PRKCD protein |
decreases activity
|
protein |
15949478
15955695 |
C085746 | 5580 |
PRKCD
MAY1 PKCD nPKC-delta |
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | [rottlerin results in decreased activity of PRKCD protein] inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA]] |
decreases activity
/ decreases reaction / increases expression / increases reaction |
protein |
22643241
|
C085746 | 5588 |
PRKCQ
PRKCT nPKC-theta |
protein kinase C, theta (EC:2.7.11.13) | rottlerin results in decreased activity of PRKCQ protein |
decreases activity
|
protein |
15691325
|
C085746 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | rottlerin inhibits the reaction [Acrolein results in increased expression of PTGS2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17363696
|
C085746 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | rottlerin inhibits the reaction [Acrolein results in increased expression of PTGS2 protein] |
decreases reaction
/ increases expression |
protein |
17363696
|
C085746 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | rottlerin inhibits the reaction [manganese chloride results in increased expression of PTGS2 protein] |
decreases reaction
/ increases expression |
protein |
19084589
|
C085746 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | rottlerin inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] |
decreases reaction
/ increases expression / increases reaction |
protein |
17640750
|
C085746 | 5894 |
RAF1
CRAF NS5 Raf-1 c-Raf |
v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) | rottlerin results in decreased phosphorylation of RAF1 protein |
decreases phosphorylation
|
protein |
15949478
|
C085746 | 5925 |
RB1
OSRC RB p105-Rb pRb pp110 |
retinoblastoma 1 | rottlerin results in decreased phosphorylation of RB1 protein |
decreases phosphorylation
|
protein |
15949478
|
C085746 | 6648 |
SOD2
IPOB MNSOD MVCD6 |
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
21705328
|
C085746 | 6648 |
SOD2
IPOB MNSOD MVCD6 |
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] |
decreases reaction
/ increases expression |
protein |
21705328
|
C085746 | 412 |
STS
ARSC ARSC1 ASC ES SSDD XLI |
steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) | rottlerin inhibits the reaction [Tretinoin results in increased activity of STS protein] |
decreases reaction
/ increases activity |
protein |
16178010
|
C085746 | 7031 |
TFF1
BCEI D21S21 HP1.A HPS2 pNR-2 pS2 |
trefoil factor 1 | [rottlerin results in decreased activity of PRKCD protein] inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA]] |
decreases activity
/ decreases reaction / increases expression / increases reaction |
mRNA |
22643241
|
C085746 | 7039 |
TGFA
TFGA |
transforming growth factor, alpha | rottlerin inhibits the reaction [irinotecan metabolite results in increased secretion of TGFA protein] |
decreases reaction
/ increases secretion |
protein |
15723263
|
C085746 | 7039 |
TGFA
TFGA |
transforming growth factor, alpha | rottlerin inhibits the reaction [irinotecan results in increased secretion of TGFA protein] |
decreases reaction
/ increases secretion |
protein |
15723263
|
C085746 | 8795 |
TNFRSF10B
CD262 DR5 KILLER KILLER/DR5 TRAIL-R2 TRAILR2 TRICK2 TRICK2A TRICK2B TRICKB ZTNFR9 |
tumor necrosis factor receptor superfamily, member 10b | rottlerin inhibits the reaction [Ursodeoxycholic Acid results in increased expression of TNFRSF10B] |
decreases reaction
/ increases expression |
21362627
|
|
C085746 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | rottlerin inhibits the reaction [VEGFA protein results in increased abundance of phosphatidylbutanol] |
decreases reaction
/ increases abundance |
protein |
14704231
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#615224 | Advanced sleep phase syndrome, familial, 2; fasps2 |
P48730
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#210900 | Bloom syndrome; blm |
P54132
|
#114480 | Breast cancer |
O96017
P31749 |
#615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#303600 | Coffin-lowry syndrome; cls |
P51812
|
#114500 | Colorectal cancer; crc |
P18054
P31749 |
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P31751
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
P18054 |
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#240900 | Hypoinsulinemic hypoglycemia with hemihypertrophy; hihghh |
P31751
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#609265 | Li-fraumeni syndrome 2; lfs2 |
O96017
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300844 | Mental retardation, x-linked 19; mrx19 |
P51812
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#259500 | Osteogenic sarcoma |
O96017
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#176807 | Prostate cancer |
O96017
|
#176920 | Proteus syndrome |
P31749
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#243060 | Spermatogenic failure 5; spgf5 |
Q9UQB9
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00881 | Li-Fraumeni syndrome |
O96017
(related)
P04637 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P31751 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P31751 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00480 | Non-syndromic X-linked mental retardation |
P51812
(related)
Q99714 (related) |
H00574 | Coffin-Lowry syndrome (CLS) |
P51812
(related)
|
H00606 | Early infantile epileptic encephalopathy |
P53779
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H01282 | Spermatogenic failure |
Q9UQB9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D058186 | C085746 | Acute Kidney Injury |
therapeutic
|
21633170
|
|
D010051 | C085746 | Ovarian Neoplasms |
therapeutic
|
21633170
|
|
D013736 | C085746 | Testicular Neoplasms |
therapeutic
|
21633170
|
|
D015431 | C085746 | Weight Loss |
therapeutic
|
21633170
|